Back

Immune checkpoint inhibitors in Cardio-Oncology: mechanisms, clinical use and complications - discussion

19 June 2026 (17:10 - 17:30)
Organised by: Logo
Congress Presentation Part of: Immune checkpoint inhibitors in cardio-oncology: mechanisms, clinical use and complications Cardio-Oncology Delegates Premium Access ESC Cardio-Oncology 2026 Council of Cardio-Oncology

4 More presentations in this session

Presentation thumbnail
Mechanisms of cardiovascular toxicity from imune checkpoint inhibitors therapy
Doctor P. Martin (Madrid, ES)
Slides Video
Presentation thumbnail
Current use of immune checkpoint inhibitors and targeted therapies: what cardiologists need to know
Doctor M. Wilk (Otwock, PL)
Slides Video
Presentation thumbnail
Case 1: acute cardiovascular complication under immune checkpoint inhibitor therapy
Doctor W. Meijers (Rotterdam, NL)
Slides Video
Presentation thumbnail
Case 2: chronic sequelae of immune checkpoint inhibitor therapy
Doctor M. Nazir (London, GB)
Slides Video

Access the full session

Session thumbnail
Immune checkpoint inhibitors in cardio-oncology: mechanisms, clinical use and complications
Video

The Event

Event poster

ESC Cardio-Oncology 2026

19 June 2026 17:10 CET

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources